The molecular basis for cross-reaction of an anti-dystrophin antibody with alpha-actinin  by James, Marian et al.
~-" A . , !  . t  
ELSEVIER Biochimica et Biophysica Acta 1360 (1997) 169-176 
BIOCHIMICA ET  B IOPHYSICA ACTA 
BB3 
The molecular basis for cross-reaction of an anti-dystrophin antibody 
with alpha-actinin 1 
Marian James a,2, Nguyen thi Man a, Yvonne H. Edwards b, Glenn E. Morris a, * 
MR1C Biochemist~ Group, The North East Wales Institute, Plas Coch, Wrexham, Clwyd, LLl l 2A W, UK 
b MRC Human Biochemical Genetics Unit, University College London, Wolfson House, 4 Stephenson Way, London, NWI 2HE, UK 
Received 23 September 1996; revised 28 November 1996; accepted 28 November 1996 
Abstract 
The epitope recognised by the anti-dystrophin monoclonal antibodies MANDYS141 and MANDYSI42 has been 
characterised using a phage display peptide library and a bacteriophage lambda cDNA library. Using a phage display library 
of random 15-mer peptides, the epitope recognised by the two antibodies was identified as EEXF. A Agtl 1 clone obtained 
by screening a human muscle cDNA library was shown to contain part of the out-of-frame human mitochondrial succinyl 
CoA synthetase (c~-subunit) cDNA sequence which contains the sequence EEPL, suggesting a minimum requirement of 
EEXF/L for antibody binding. The sequence EEDF is located in the helical rod region of dystrophin and the N-terminal 
domain of c~-actinin; this may explain why native dystrophin is not detected, since the t~-helical, coiled-coil folding of the 
rod region of dystrophin may obscure the epitope in the native protein. The antibody cross-reaction between dystrophin and 
c~-actinin is likely to be fortuitous and not due to any structural homology that exists between these two members of the 
spectrin superfamily. 
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1. Introduction 
Cross-reaction of antibodies with proteins other 
than the original immunogen can cause autoimmune 
disease as well as creating difficulties in diagnostic 
and research applications. In some autoimmune dis- 
eases, antibodies generated against invading micro- 
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organisms also cross react with self-antigens [1] and 
establishment of the molecular basis for antibody 
cross-reactions is clearly important for understanding 
the pathology of this important group of human 
diseases. Cross-reactions may also seriously reduce 
antibody specificity in immunoassays and diagnostic 
tests and they can lead to confusion in analysis of 
research data. For this reason, we have advocated the 
use of panels of monoclonal antibodies (mAbs) 
against different epitopes (rather than single mAbs) 
for characterization f novel protein antigens [2-4]. 
One of the earliest examples of a striking mAb 
cross-reaction was shown by an antibody which re- 
acted with both vimentin and tropomyosin although it 
recognised one of them on Western blots (denatured 
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antigen) and the other in an immuno-precipitation test
(native antigen) [5]. We have described a rather 
similar cross-reaction problem with two mAbs, 
MANDYS141 and MANDYS142, raised against he 
central rod region of dystrophin [6], the protein shown 
to be absent in Duchenne muscular dystrophy pa- 
tients [7]. Both of these antibodies cross react with 
the structurally related protein, a-actinin, and they 
recognise both native a-actinin in frozen tissue sec- 
tions and denatured o~-actinin on Western blots, 
whereas only the denatured form of dystrophin is 
recognised [6]. Both proteins belong to the spectrin 
'superfamily', so, although the homology at the amino 
acid sequence l vel in their central helical domains is 
not great [8], the possibility that the mAbs recognised 
a common structure on both proteins, produced by 
the coiled-coil folding of the primary sequences, was 
seriously considered. Although it was raised against 
dystrophin, MANDYS141 appears, in practice, to be 
a valuable and highly-specific mAb for studying a- 
actinin in skeletal muscle by both immunolocaliza- 
tion and Western blotting. Thus, it has been used to 
demonstrate he localisation of o~-actinin i  nemaline 
bodies in congenital nemaline myopathy patients us- 
ing both immunofluorescent a d electron microscopy 
techniques [9]. 
In the present study, we have used a phage display 
peptide library to show that the epitope recognised by 
MANDYS141 and MANDYS142 includes the 
amino-acid sequence, EEDF, present in the coiled-coil 
rod domain of dystrophin and in the N-terminal 
domain of a-actinin. We also screened a human 
skeletal muscle cDNA library in Agtll with the 
mAbs and isolated a novel cDNA which has proved 
to be a product of the human mitochondrial succinyl 
CoA synthetase (a-subunit) gene. The sequence was 
extended to the N-terminus of the protein by 5'-RACE 
(EMBL accession umber Z68204). 
2. Materials and methods 
2.1. Materials 
The mouse monoclonal antibodies MANDYS141 
and MANDYS142 have been described previously 
[6]. The synthetic peptides PI: EIQQGVNL- 
KEEDFNKD and P2: EEDFNKDMNEDNEGTV 
were prepared by Alta Bioscience (University of 
Birmingham, UK). The 15-mer peptide library (in the 
fUSE5 filamentous phage vector) used was a gener- 
ous gift from Prof. George P. Smith (University of 
Missouri, USA), along with sequencing primers and 
appropriate bacterial cell lines. Unless otherwise 
stated, all other reagents were from Sigma (Poole, 
Dorset, UK). 
2.2. Phage display peptide library 
Petri plates were coated with rabbit anti-(mouse 
Ig) (DAKO, High Wycombe, UK), diluted 1:1000 
with PBS (0.9% NaC1, 25 mM sodium phosphate, pH 
7.2), to capture MANDYS 142 Ig from culture super- 
natant (diluted 1:100 in PBS). These plates were then 
used for four successive rounds of bio-panning of the 
15-mer library as described elsewhere [10,11]. Isola- 
tion of phage DNA and sequencing have also been 
described [10,11]. 
2.3. Agtll human muscle cDNA library 
In order to isolate cDNAs encoding proteins con- 
taining cross-reacting epitopes, an adult human skele- 
tal muscle library in the Agtl 1 vector was screened. 
The library contains 0.8 × 106 independent recombi- 
nants and complete and partial cDNAs ranging in 
size from 0.5 to 3.0 kb have been isolated from it 
[12]. 
The cDNA library was plated and filter lifts were 
screened with a MANDYS141 mAb probe as de- 
scribed in [24]. The library filters were blocked in 3% 
skimmed milk in IB for 30 min. After three 5-min 
washes in PBS, the mAb culture supernatant diluted 
1/50 in IB / I% horse serum/ l% fetal calf 
serum/0.1% BSA was added and the filter was 
incubated at room temperature for lh. After a further 
four washes in PBS, the blots were incubated with 
biotinylated anti-mouse Ig and a detection reagent 
(Vectastain ABC Elite, Vector Laboratories, Peter- 
borough, UK). After four 5-min washes in PBS the 
blots were developed with substrate (0.4 mg/ml  
diaminobenzidine i  25 mM phosphate-citrate buffer, 
pH 5.0, with 0.012% H202). 
Positive plaques were picked off the agar plate 
using a Pasteur pipette and allowed to elute from the 
agar into 0.5 ml lambda diluent/l% chloroform 
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overnight at 4°C. Infection and plating procedures 
were repeated twice by which time all plaques from 
the eluate were antibody-positive. 
2.4. PCR amplification 
The insert from the isolated positive Agtl 1 plaque 
was amplified by PCR using the following Agtll 
primers: 
Forward: 5'-ggtggcgacgac t cc tggagcccg 
Reverse: 5'-t tgacaccagaccaactggtaatg 
40 /xl of eluted Agtl 1 was added to 34/~1 dH20 
and incubated at room temperature for 30 min. 10 ~1 
of 10X PCR buffer (500 mM KC1, 100 mM Tris-HC1 
pH 8.4, 15 mM MgC12), 5 /xl dNTP (2.5 mM dATP, 
2.5 mM dCTP, 2.5 mM dGTP, 2.5 mM dTTP), 5 /zl 
forward primer (2 /zM), 5 /xl reverse primer (2 /zM) 
were added to the diluted lambda. The reaction was 
covered with a layer of mineral oil and heated to 
94°C for 4 min. 2.5 U of Taq polymerase was added 
and 30 cycles of PCR (72°C for 1 min., 56°C for 30 s 
and 94°C for 20 s per cycle) were performed using a 
thermal cycler. 
The 100/zl reaction was separated on a 2% agarose 
gel containing ethidium bromide (0.5 /zg/ml) and a 
band of approximately 400 bp was excised and 
weighed. The DNA was extracted from the agarose 
using the QIAGEN gel extraction kit (Diagen, Dus- 
seldorf, Germany) according to manufacturers in- 
structions. The DNA was concentrated in 20 /xl of 
dH20. 
2.5. Cloning and sequencing 
0.2 pmol of purified PCR product was ligated into 
50 ng of the T-overhang pT7 blue plasmid (Novagen, 
Madison, WI, USA) using T4 ligase (2.5 Weiss units) 
at 16°C for 4 h in a total volume of 10 /zl. 1 /~1 of 
the ligation mixture was transformed into 20 /zl 
Novablue competent cells (Novagen) for 'blue-white' 
screening. 
Colonies containing DNA insert were screened by 
PCR using pT7 primers. Double stranded plasmid 
DNA mini-preps were denatured using 2N NaOH at 
room temperature for 5 min, before the addition of 5 
M ammonium acetate. The DNA was extracted with 
phenol:chloroform, precipitated with ethanol and dis- 
solved in 20/zl  of dH20. The DNA mini-preps from 
positive colonies were sequenced using both pT7 
primers and Agtl 1 primers with the Sequenase ver- 
sion 2.0 DNA sequencing kit (Amersham Interna- 
tional, High Wycombe, UK). 
pT7 primers: 
Forward: 5'-taatacgactcactataggg 
Reverse: 5'-ggt t t tcccagtcacgacgt  
2.6. RACE 
RACE (Rapid Amplification of cDNA Ends) is a 
method of amplifying beyond the region of known 
sequence. The kit supplied by Clontech (Cambridge, 
UK) consists of a human fetal brain cDNA library in 
which all the DNA fragments have an anchor se- 
quence at the 5' end and a PCR primer which recog- 
nises this anchor sequence. A nested PCR was carried 
out using the anchor primer and two reverse primers 
within the known sequence and the final PCR prod- 
uct was sequenced irectly using the Sequenase PCR 
product sequencing kit (Amersham International). 
Human mitochondrial succinyl CoA synthetase in- 
ternal primers: 
1st round PCR: 5'-gcctgctggctgtcaaaggtgccc 
2nd round PCR: 5'-cgagaagc tgtgtaggaacaatg¢ 
(a) 
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Fig. 1. Demonstration f the specificity of the MANDYSI41 
monoclonal ntibody for (a) both dystrophin and a-actinin on 
Western blots and (b) c~-actinin only in immunofluorescence 
microscopy. SDS-PAGE (3-12.5% gradient gels)/Western blot- 
ting of total protein extracts of human skeletal muscle and 
immunofluorescence microscopy of frozen sections of human 
muscle have been described elsewhere [2,6]. 
172 M. James et al. / Biochimica et Biophysica Acta 1360 (1997) 169-176 
3. Results 
Fig. la shows that only two major protein bands, 
identified as dystrophin and c~-actinin [6], are de- 
tected by MANDYS141 on Western blots of total 
skeletal muscle proteins. Immunofluorescent staining 
of frozen sections of human skeletal muscle shows 
the cross-striations consistent with the localisation of 
ce-actinin at the Z-line, but the clear, sharp staining of 
the sarcolemma seen with other anti-dystrophin mAbs 
[3] is not seen with MANDYS141 (Fig. lb). 
MANDYS142 gave the same results, which suggest 
that these mAbs recognise dystrophin only in its 
denatured form but recognise ~-actinin in both native 
and denatured forms. 
We subjected a phage display peptide library of 
random 15-mers to four rounds of biopanning with 
MANDYS142. Fig. 2 shows that, after the fourth 
round of panning, 23 of the 24 randomly selected 
colonies displayed a peptide which was recognised 
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5 
a) MANDYS 141 b) MANDYS 142 
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c) MANDYS141 + P1 d) MANDYS141 + P2 
Fig. 2. Binding of (a) MANDYS141 and (b) MANDYS142 to colonies isolated from the phage display library and the effect of (c) 
peptide PI and (d) peptide P2 on MANDYS141 binding. Individual colonies were selected and plated firstly onto a master plate 
(LB/kanamycin (100 /zg/ml)/tetracycline (40/~g/ml)) and also onto a nitrocellulose sheet placed carefully on a LB/kanamycin/tetra- 
cycline plate. Colonies were grown overnight at 37°C. The bacterial colonies were washed from the filter with TBST (150 mM NaC1, 50 
mM Tris-HC1, pH 7.5, 0.5% Tween-20) using a sponge. The nitrocellulose was then washed three times for 2 min. in TBST before 
blocking for 30 min in 3% skimmed milk in TBS (150 mM NaC1, 50 mM Tris-HCl, pH 7.5). After four washes, the antibody culture 
supernatant diluted 1/50 in IB (25 mM sodium phosphate pH 7.2, 0.9% NaC1, 0.05% Triton X-100, 1% horse serum, 1% fetal calf serum 
and 0.1% bovine serum albumin) was added and the filter was incubated at room temperature for lh with shaking. Filters were washed a 
further four times in TBST before incubation with a peroxidase-conjugated anti-mouse Ig antibody (DAKO) diluted 1 f 1000 in IB for I h 
at room temperature. The filter was then washed four times in TBST and developed in substrate (0.4 mg/ml  diaminobenzidine i  25 mM 
phosphate-citrate buffer pH 5.0 with 0.012% H202). Competition assays were performed in the same way except hat the monoclonal 
antibody supernatant was pre-incubated with the peptide (50 /xg/ml) for 30 min at room temperature. 
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Peptide sequence (Phage) RHM~ ~_EESF~RPFWA 
Dystrophin sequence (Human) VNLI~ ~EDF~KDI~qED 
c~-actinin sequence (Chick) IENJ ~.EDF~DGLKLM 
Lambda 
sequence 
SIVPTQLLGNISMLIKIQRLFARVSLANRAPFTASRHWNMAP 
NS~GKEARHIWAYLSLIL(Stop) 
Fig. 3. Comparison of the peptide sequence obtained from the 
phage display library with dystrophin and c~-actinin sequences 
containing the MANDYS141/142 epitope and amino acid se- 
quence expressed in the 'wrong' reading frame by the isolated 
bacteriophage Agtl I clone containing human mitochondrial suc- 
cinyl CoA syntbetase cDNA. The likely epitope sequences are 
boxed. 
by both MANDYSI41 (Fig. 2a) and MANDYS142 
(Fig. 2b). Only one colony, A4, failed to react with 
either MANDYS141 or MANDYS142. E5 is a nega- 
tive control selected from the library using a different 
antibody. To show that the phage displayed peptides 
were binding specifically, a competition test was 
performed using a 16-mer dystrophin peptide (P1) 
previously shown to bind to MANDYS141 and 142 
in an ELISA assay [13]. Fig. 2c shows that pre-in- 
cubation of the antibody with P1 prevented mAb 
binding to the phage display peptides immobilised on 
the nitrocellulose filter. Peptide P2 does not bind to 
either MANDYS141 or MANDYS142 (results not 
shown) and did not prevent mAb binding to the 
displayed peptides (Fig. 2d). The peptide inserts from 
four of the positive phage display colonies were all 
found to carry the same sequence shown in Fig. 3. 
Comparison with the antibody-binding peptide, P1, 
suggests that the amino acid sequence EEXF is part 
of the epitope, as this is the only region of shared 
sequence (Fig. 3). The sequence EEDF was found to 
be present in the N-terminal domain of ce-actinin 
(residues 56-59), whereas the EEDF epitope in dys- 
trophin lies in the central rod region (residues 1809- 
1812) (Fig. 3). The first four residues of the peptide 
P2 are EEDF but P2 does not bind to MANDYS141 
and 142. However, the presence of a free amino 
group, rather than a peptide bond, on the first glu- 
tamic acid residue would be expected to have signifi- 
cant effect on protein-protein teractions and may 
prevent mAb binding. 
Partial chemical cleavage fragments of chick ac- 
tinin confirm the epitope localization; in an earlier 
study [6], we showed that MANDYS141 recognises a 
cysteine-cleavage fragment which migrates on SDS- 
PAGE about halfway between 37kD and 43kD size 
markers. There are nine cysteine residues in chick 
actinin and the only predicted partial digestion frag- 
ment within this size range covers residues 1-333 
(38.8 kDa) which includes the EEDF sequence; the 
only other predicted fragments of similar size are 
outside this range (34.2 kDa and 34.4 kDa, or 44.1 
kDa, 47.6 kDa and 50.1 kDa). 
When MANDYS142 was used to screen a bacte- 
riophage Agtl 1 human skeletal muscle cDNA library, 
two positive clones were identified and sequenced. 
The first, containing 1465 bp, was found to be a 
dystrophin cDNA fragment, which contained the 
EEDF-encoding sequence. This was unexpected since 
this sequence lies 6 kb from the poly-A tail in the 
3'-UTR and most cDNAs in this oligo-dT primed 
library would be considerably smaller than 6 kb. 
However, sequencing revealed that the inclusion of 
this cDNA in the library was due to priming on a run 
of eight adenines at nucleotides 5690-5697 of the 
open reading frame, less than 0.3 kb after the EEDF 
encoding sequence. The second, 321 bp cDNA se- 
quence was a novel sequence which showed no ho- 
mology to either the dystrophin or c~-actinin cDNA 
sequences. A BLAST search of the GenBank and 
EMBL databases showed that the sequence is almost 
identical to a rat mitochondrial succinyl CoA syn- 
thetase sequence. The sequence xpressed by the 
lambda clone, however, was in the incorrect reading 
frame. Fig. 3 shows the predicted protein sequenced 
expressed from the out-of-frame mRNA; translation 
would be terminated by a stop codon after 64 amino 
acids. The only amino-acid sequence identity with the 
proposed antibody binding site in dystrophin and 
c~-actinin is two glutamic acid residues (EE) at posi- 
tions 46 and 47 (Fig. 3). This suggests that the EEPL 
sequence here permits sufficient MANDYS 142 bind- 
ing for Agtll clone detection, though the binding 
may be weaker than to the EEDF sequence. 
Using a 5'-RACE human brain cDNA library, we 
were able to extend the mitochondrial succinyl CoA 
synthetase sequence into the 5'-UTR and the corn- 
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Human:  
Rat :  
Taq  
Eco  
MVSGSNGLAAARLLSRSFLLQQNGIQHCSYTASRQHLYVDKNTKI ICQ 
S T R G KNI  I V 
S tar t -V ILVNRETRVLV 
Star t -S IL I  V 
Human 
Rat  
Taq  
Eco  
GFTGKQGTFHSQQALEYGTKLVGGTTPGKGGQTHLGLPVFNTVKEAKE 
KK  
I RE  Q TK  M D I A V TEV V YD VA 
S E IA  M V T R VA 
Human QTGATASVIYVPPPFAAAAINEAIEAE IPLWCITE/  
Rat  K D / 
Taq  HHEVD I F A A D AL  AH G I L / 
ECO A A CKDS L D G K I IT  / 
Fig. 4. Amino acid sequence of human succinyl CoA synthetase deduced from the nucleotide sequence and compared with sequences 
from rat [14], T. aquaticus (Taq) [22] and E. coli (Eco) [23]. 
bined protein sequences, 40% of full-length, are 
shown in Fig. 4. The enzyme is highly-conserved and 
amino-acid sequences from rat, Thermus aquaticus 
(Taq) and Escherichia coli (Eco) are aligned in Fig. 
4 to illustrate this. The first 27 amino-acids are the 
signal sequence for translocation i to mitochondria 
[14]. The bacterial sequences lack this and also lack a 
further 8 residues at the N-terminus. Outside the 
signal sequence, there are only 9 amino-acid iffer- 
ences between the rat and human enzymes; 7 of 
which are also different in the Taq and Eco se- 
quences and the other two are conservative changes 
(lie to Leu and Val to lie). Products from three 
separate PCR reactions were sequenced to check for 
possible PCR errors and their sequences were identi- 
cal. 
4. Discussion 
Striking and unexpected cross-reactions of mono- 
clonal antibodies are not uncommon [ 15-17]. In many 
cases, these cross-reactions are due to fortuitously 
shared sequences of no apparent functional or struc- 
tural significance. In some cases, however, signifi- 
cant relationship between the two antigens exists, a 
good example being antibodies against dystrophin 
which cross-react with the dystrophin-related protein, 
utrophin [3], and vice versa [2]. It has been suggested 
that dystrophin and utrophin are members of a pro- 
tein superfamily which also includes spectrin and 
a-actinin [18]. All members have a central rod-region 
of helical repeats separating an N-terminal, actin 
binding domain from a C-terminal, Ca 2+ binding 
domain. However, the helical repeats in dystrophin 
and utrophin are less regular [19] and the structural 
homology with spectrin may be less strong than 
originally considered [20]. The sequence similarity 
between dystrophin and utrophin is so great [21] that 
they can reasonably be considered to be isoforms, 
whereas they have very little sequence similarity with 
a-actinin and spectrin. Our present study, however, 
shows that the cross-reaction of MANDYS 141 / 142 
with a-actinin does depend on a small region of 
sequence identity with dystrophin, rather than any 
structural similarity. 
We had previously localised the MANDYS141/ 
142 epitope to a 16-amino acid sequence ncoded by 
exon 38 of the dystrophin gene [13]. Screening a 
phage display peptide library has now enabled us to 
pin-point the epitope to the short sequence EEDF 
which is present in both dystrophin and ce-actinin. In 
native dystrophin, the sequence appears to be buried 
in the central rod, helical coiled-coil structures and 
inaccessible to the antibodies until the structure is 
disrupted uring SDS-PAGE and Western blotting. In 
a-actinin, the EEDF sequence is in the N-terminal 
region and is evidently accessible in both the native 
and denatured protein. After using MANDYS142 to 
screen a human skeletal muscle cDNA library in 
Agtl 1 we have further defined the minimum require- 
ment for mAb binding to EEXF/L.  The two glu- 
tamic acid residues appear to be most important for 
mAb binding, the third residue may be D, S, or P and 
there appears to be a requirement for a hydrophobic 
residue (F or L) at the fourth position. The epitope 
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must be flanked by a peptide bond on the N-terminal 
side, since peptide P2, in which the first Glu residue 
has a free amino-group, is not recognised by the 
mAbs. 
The sequences EEXF/L  and EEDF are both very 
common in the protein sequence databases, but the 
mAbs only bind dystrophin and a-actinin on Western 
blots (see Fig. 1). ~-actinin may be detected because 
it is particularly abundant in muscle but there may 
also be additional residues in the dystrophin immuno- 
gen, which are non-essential but nevertheless con- 
tribute to mAb binding affinity (i.e. EEDF may be 
the minimal, but not complete, epitope). Relative 
abundance, affinity and residual structure may all 
contribute to the absence of other protein bands on 
Western blots. It must be emphasized, however, that 
binding to a-actinin is not a weak cross-reaction of
the type displayed by many mAbs; MANDYS141 
can be used to detect a-actinin in human muscle 
quite specifically and very effectively by immunohis- 
tochemistry, immunoelectron microscopy and West- 
ern blotting, as illustrated by recent studies on a- 
actinin-containing emaline bodies in congenital my- 
opathy patients [9]. 
The finding that c~-actinin was not detected in a 
cDNA library screen using MANDYS141 is not sur- 
prising, since the reactive epitope lies near the N- 
terminus. Since the cDNA library was oligo-dT 
primed, only large a-actinin cDNAs (> 3 kb) would 
be detected by this mAb and these are likely to be 
rare. It is true that a dystrophin cDNA was isolated, 
although the epitope-encoding region is over 6 kb 
from the polyA tail, but this was due to priming on 
an internal stretch of 8 A's in the dystrophin mRNA 
sequence. Especially in oligo-dT-primed libraries, 
positive plaques will be detected less frequently by 
mAbs than by polyclonal antisera, since the latter 
behave as mixtures of several mAbs, some of which 
are likely to bind close to the C-terminal end of the 
protein. Ironically, although we did not obtain any 
ce-actinin cDNA clones, we did succeed in cloning a 
novel human cDNA, but one which expressed a 
MANDYS141 cross-reacting amino-acid sequence 
only when translated in the wrong reading-frame. The 
human mitochondrial succinyl CoA synthetase a- 
subunit gene had not previously been sequenced, so 
we designed PCR primers to extend the sequence into 
the 5'-UTR by cDNA-RACE. The homology between 
the human and rat sequence is extensive with 90% 
identity at the amino acid level. 
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